Ucb SA

Common Name
Ucb
Country
Belgium
Sector
Healthcare
Industry
Biotechnology
Employees
8,600
Ticker
UCB
Exchange
EURONEXT
Description
UCB S.A. is a global biopharmaceutical company that focuses on developing innovative medicines and sustainable solutions for patients living with severe diseases. Specializing particularly in the fiel...

Financial Statements of Ucb

Below are the financial statements of Ucb, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of EUR20242023
Continuing operations
Net sales
5,613a
4,867a
Royalty income and fees
78a
77a
Other revenue
461a
308a
Revenue
6,152a
5,252a
Cost of sales
-1,752a
-1,707a
Gross profit
4,400a
3,545a
Marketing and selling expenses
-2,075a
-1,594a
Research and development expenses
-1,781a
-1,630a
General and administrative expenses
-272a
-230a
Other operating income/expenses (-)
564a
566a
Operating profit before impairment, restructuring and other income and expenses
836a
657a
Impairment of non-financial assets
-73a
-5a
Restructuring expenses
-25a
-13a
Other income/expenses (-)
586a
-35a
Operating profit
1,324a
604a
Financial income
39a
47a
Financial expenses
-200a
-210a
Profit before income taxes
1,163a
441a
Income tax expense
-98a
-98a
Profit from continuing operations
1,065a
343a
Profit/loss (-) from discontinued operations
0a
0a
Profit
1,065a
343a
Attributable to
Equity holders of UCB SA
1,065a
343a
Non-controlling interests
0a
0a
Download Data

Verified Sources Behind Ucb’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ucb’s data sources below and access millions more through our Disclosure Search.

a. Ucb's Integrated Report 2024
a. Ucb's Integrated Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?